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Most  Escherichia  coli  strains  are  naturally  unable  to grow  on 1,2-propanediol  (PDO)  as a  sole  carbon
source.  Recently,  however,  a K-12  descendent  E. coli  strain  was  evolved  to  grow  on 1,2-PDO,  and  it
was  hypothesized  that  this  evolved  ability  was  dependent  on  the  aldehyde  dehydrogenase,  AldA,  which
is  highly  conserved  among  members  of  the  family  Enterobacteriacea.  To  test this  hypothesis,  we  ﬁrst
performed  computational  model  simulation,  which  conﬁrmed  the essentiality  of  the  aldA  gene  for  1,2-
PDO utilization  by  the evolved  PDO-degrading  E.  coli.  Next,  we  deleted  the  aldA  gene  from  the  evolved
strain,  and  this  deletion  was  sufﬁcient  to  abolish  the  evolved  phenotype.  On  re-introducing  the  gene  onenome-scale models
daptive laboratory evolution
athway gap ﬁlling
a  plasmid,  the  evolved  phenotype  was  restored.  These  ﬁndings  provide  experimental  evidence  for  the
computationally  predicted  role of  AldA  in  1,2-PDO  utilization,  and  represent  a good example  of  E.  coli
robustness,  demonstrated  by the  bacterial  deployment  of a  generalist  enzyme  (here  AldA)  in  multiple
pathways  to survive  carbon  starvation  and  to grow  on  a non-native  substrate  when  no  native  carbon
source  is available.
© 2016  Elsevier  GmbH.  All  rights  reserved.. Introduction
Advances in sequencing technology and accumulation of
enomic information accelerated the discovery and exploitation of
ovel pathways in medically and industrially important microor-
anisms. Nevertheless, even 20 years after the ﬁrst microbial
enome was sequenced (Fleischmann et al., 1995), the encoded
unctions of over 40% of sequenced microbial genes remain unde-
ermined (Aziz et al., 2012). Even more intriguingly, novel functions
re still being discovered for genes with previously established
oles, as revealed by systematic gene deletion investigations (e.g.,
aba et al., 2006) and adaptive laboratory evolution (ALE) experi-
ents (Conrad et al., 2011).
Abbreviations: 1,2-PDO, 1,2-propanediol; ALE, Adaptive laboratory evolution;
12PDO, Evolved E. coli K-12 capable of growth on L-1,2-PDO.
∗ Corresponding author at: Department of Microbiology and Immunology, Faculty
f  Pharmacy, Cairo University, 11562, Cairo, Egypt.
∗∗ Corresponding author at: The Novo Nordisk Foundation Center for Biosustain-
bility, Technical University of Denmark, 2970 Hørsholm, Denmark.
E-mail addresses: ramy.aziz@gmail.com (R.K. Aziz), pcharusanti@ucsd.edu
P. Charusanti).
ttp://dx.doi.org/10.1016/j.micres.2016.10.006
944-5013/© 2016 Elsevier GmbH. All rights reserved.As an example, one experimentally well-studied pathway that
is still being explored on the genomic level is the propanediol
utilization pathway. 1,2-propanediol (PDO: PubChem ID: 1030,
CAS# 57-55-6), also known as propylene glycol, is a water-miscible
organic solvent commonly used in industrial and medical applica-
tions (O’Neil, 2006). In industry, 1,2-PDO is a substrate in polymer
production and an approved food additive (E# 1520) (Niu and Guo,
2015). In medicine, it is used as an antiseptic, a vehicle for intra-
venous and dermatological formulations, as well as a hygroscopic
agent in respiratory inhalants (Bennett and San, 2001). Moreover,
there is mounting evidence that 1,2-PDO plays a key role in the
metabolic activities of human gut microbiota (Pacheco et al., 2012;
Staib and Fuchs, 2014).
Theoretically, E. coli has the potential to catabolize 1,2-PDO
through one of two  pathways. The ﬁrst involves the propanediol-
utilization (PDU) locus, which only some strains possess (Monk
et al., 2013). The second has been hypothesized to involve the
aldehyde dehydrogenase, aldA. Several research groups have sug-
gested a key role for this gene since AldA is the only enzyme in
the E. coli genome annotated to oxidize the intermediate product
L-lactaldehyde to L-lactate (Hacking et al., 1978; Chen et al., 1987;
Zhang et al., 2006). No deﬁnitive experimental proof, however, has
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een provided to support this hypothesis, in large part because this
ldA-associated pathway is not active in wild-type E. coli isolates,
hich naturally fail to utilize 1,2-PDO as a carbon source.
A recent study reported the use of ALE to generate a strain
f E. coli K-12 MG1655 that can grow in deﬁned media with L-
,2-PDO as the sole carbon source and in the absence of the PDU
ocus (Lee and Palsson, 2010); yet, the biochemical basis of the
volved mechanism was not fully deciphered. Here, we  used this
aboratory-evolved strain to test and conﬁrm the hypothesis that
ldA does indeed play a key role in 1,2-PDO utilization through
omputational modeling and experimentation
. Materials and methods
.1. Bacterial strains and culture conditions
Two Escherichia coli K-12 MG1655 strains were used in this
tudy: the wild type and a descendant that had been evolved to uti-
ize 1,2-PDO as the primary carbon source (Lee and Palsson, 2010).
acteria were maintained on Luria Bertani (LB) broth or plates.
arbon source and growth curve experiments were performed in
9 minimal media (Fong et al., 2013) supplemented with glu-
ose (Sigma, St. Louis, MO)  M9-glucose, or with L-1,2-propanediol
Sigma, St. Louis, MO), M9-PDO. In M9-glucose, glucose was  added
t 2 g/L concentrations, whereas L-1,2-PDO was added to M9-PDO
t 1, 2, 4, or 8 g/L according to the experimental design. Ampicillin,
anamycin, and chloramphenicol (Sigma, St. Louis, MO)  were added
or selection of transformed strains to ﬁnal concentrations of 100,
0, and 25 ug/mL, respectively.
Cultures were routinely tested for purity on MacConkey or
osin-Methylene Blue agar plates.
.2. Plasmids
pKD46, pKD13, pCP20 were used for precise gene deletion by the
ambda Red system according to Baba and coworkers’ modiﬁcation
Baba et al., 2006) of the original protocol described by Datsenko
nd Warner (Datsenko and Wanner, 2000). pASK1988 was  used for
ene complementation exactly as previously described (Fong et al.,
013).
.3. Computational genomic screening and pathway analysis
Genomic screening for AldA homologs and paralogs was per-
ormed on the SEED genome analysis servers (Aziz et al., 2012).
peciﬁcally, the “Compare Region” tool in the SEED server was used
o ﬁnd major homologs of the E. coli AldA-encoding gene; then
ll conﬁrmed orthologs of the gene (deﬁned as bidirectional best
its) were downloaded from the SEED database. Absence of other
ldA copies in E. coli and absence of the gene was investigated by
he “Browse Subsystems” feature in the SEED database (Aziz et al.,
012). Further sequence analysis and conﬁrmation of gene pres-
nce/absence were performed by BlastP and tBLastN (Altschul et al.,
997).
The COBRApy toolbox (Ebrahim et al., 2013) and Escher visual-
zation tool (King et al., 2015) were used for pathway investigation
f the role of AldA in PDO utilization.
.4. Construction of deletion mutants and genetic
omplementation
The Lambda Red system, originally developed by Datsenko and
arren (Datsenko and Wanner, 2000), was used for precise gene
eletion according to the modiﬁed protocol used in creating the
eio collection (Baba et al., 2006). Primers used for construction of
he knockout strain and conﬁrmation of aldA deletion have beenesearch 194 (2017) 47–52
described in our recent work (Aziz et al., 2015b). Genetic comple-
mentation with aldA-carrying pASK plasmid was used exactly as
described (Fong et al., 2013).
2.5. Analysis of aldA transcription by real-time reverse
transcriptase polymerase chain reaction (real-time RT PCR)
RT-PCR experiments and measurements were carried out in a
CFX96 C1000 Touch instrument running CFX Manager software
version 3.0.1224.1015 (Bio-Rad Hercules, CA). All experiments
were in accordance with the MIQE guidelines (Bustin et al., 2009;
Bustin et al., 2013).
RNA was extracted by the RNeasy kit (Qiagen, Valencia, CA)
from three biological replicates of each strain grown to mid-log
phase. RNA concentration and quality were checked by a NanoDrop
instrument (Thermo Fisher, Waltham, MA).
SuperScript III reverse transcriptase was used for ﬁrst strand
cDNA synthesis, in presence of 10 mM dNTPs, random primers,
DTT, 1 st strand buffer, the RNase inhibitor, Superase-In, and DEPC-
treated water, all purchased from Life Technologies (Carlsbad, CA).
Thermocycler conditions for annealing of random primers were
70 ◦C for 10 min; 25 ◦C for 10 min; 4 ◦C hold. The mixture was  sub-
sequently added in its entirety to reagents for ﬁrst strand synthesis,
for which the thermocycler conditions were: 25 ◦C for 10 min; 37 ◦C
for 60 min; 42 ◦C for 60 min; 70 ◦C for 10 min; 4 ◦C hold. Next, 20 L
of a 1 N NaOH solution was  added to the mixture and incubated at
65 ◦C for 30 min, after which 20 L of a 1 N HCl solution was added
to neutralize. The cDNA was  then puriﬁed with the Qiagen PCR
puriﬁcation kit. The quantity and purity were again measured in
Nanodrop and Qubit instruments (Thermo Fisher, Waltham, MA),
and the integrity was measured with a Bioanalyzer (Agilent Tech-
nologies, Santa Clara, CA).
The housekeeping genes used for normalization were ihfB, hcaT,
and idnT (Zhou et al., 2011). Primer sequences and product lengths
for these three genes, plus that for aldA, are provided in Table 1.
The RT-PCR cycling conditions were: 98 ◦C for 6 min  followed
by 65 cycles of 98 ◦C for 15 s, 55 ◦C for 15 s. The reagents were 1 L
each of the forward and reverse primers in which the stock concen-
trations were 1 M,  5 L of SsoAdvanced SYBR green mix (Bio-Rad,
Hercules, CA), 10 ng of cDNA, and water up to 10 L ﬁnal volume.
A similar mixture was used to determine the efﬁciency for each
primer set, but genomic DNA (gDNA) replaced the cDNA and a
series of ﬁve serial dilutions were used. The highest concentration
of gDNA was 10 ng, and each of the dilutions differed in concen-
tration by 1/10. An additional well containing no gDNA was also
added to the melt curve analysis.
The threshold cycle (Ct) for each sample was calculated using
the single threshold, baseline subtracted curve ﬁt algorithm sup-
plied with the CFX Manager software. Ct values for no template
control (NTC) wells were routinely 35 and higher, whereas for sam-
ple wells, these values ranged between 10 and 20. Normalization
of the aldA transcript levels to the housekeeping genes was  also
calculated with the same software.
2.6. Phenotypic screens and growth experiments
Phenotypic screens were performed on LB, M9,  M9-glucose, or
M9-PDO. All growth experiments were performed in replicates
(3–6 technical replicates and at least two biological replicates) in
100-well plates that were loaded into the Bioscreen C instrument
(Oy Growth Curves Ab Ltd, Finland) and measured automatically
every 20 min  at 37◦ C for up to 48 h, after 10-s shaking prior to each
measurement. Readings were copied to Microsoft Excel, and the
growth rate was  calculated as the slope of the logarithmic best-ﬁt
line during exponential growth.
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Table  1
Primer sequences used for RT-PCR assays.
Target gene Primer name Primer sequence Product length
aldA aldA-RT-FaldA-RT-R 5′-GAACGTGCACAACCAGAATG-3′
5′-CCTGGACGATCGCTTTGAATA-3′
239
ihfB  ihfB-RT-F ihfB-RT-R 5′-GATAGAAAGACTTGCCACCCA-3′
5′-CCAGTTCTACTTTATCGCCAG-3′
200
hcaT  hcaT-RT-FhcaT-RT-R 5′-CGTTGCCGTGGTTGATAGT-3′
5′-CGTGGCCCAGATATTGATACA-3′
201
5′-CCCTCCTTCTGGAACAGTATT-3′
5′-TCGATGGTGCGTCCATTAC-3′
200
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Fig. 1. Model-based hypothesis about the role of AldA in L-1,2-PDO utilization.
In  the evolved strain (A), L-1,2-PDO is oxidized to L-lactaldehyde, which can beidnT  idnT-RT-FidnT-RT-R 
. Results
.1. aldA is highly conserved in E. coli and enterobacteria
A survey of aldA orthologs in bacterial genomes showed the
igh conservation of this gene in E. coli strains as well as in other
nterobacteria. Overall, 1742 putative orthologs of E. coli aldA have
een detected across different bacterial genomes, including some
f the closest E. coli phylogenetic relatives such as Shigella, Citrobac-
er, Klebsiella, and Enterobacter. AldA (accession # NP 415933.1)
s highly conserved among enterobacteria, and the amino acid
equence identity among enterobacterial AldA homologs ranges
rom 71 to 100% (with tBlastN E-values <10−100). Curiously, no AldA
rtholog was  found in any Salmonella species, which are among
. coli’s closest phylogenetic neighbors (conﬁrmed by tBlastN
Altschul et al., 1997) search for any unannotated or pseudo-
enes within all available Salmonella genomes). Alternatively, the
. enterica protein with highest similarity to AldA was  found to be
ADP-dependent succinate-semialdehyde dehydrogenase (acces-
ion # WP  001176519.1), a paralog of AldA that is conserved among
nterobacteria, including E. coli (Accession # WP  000772831.1).
.2. Computational pathway simulation suggests a role for AldA
n L-1,2-PDO utilization
To test the possibility that AldA plays a role in the evolved ability
f E. coli to grow on 1,2-PDO (Lee and Palsson, 2010), we applied the
ost recent genome-scale models for E. coli (Monk et al., 2013) to
omputationally investigate whether the aldA gene product would
e essential when the laboratory-evolved E. coli K12PDO strain is
imulated to grow in M9  medium with L-1,2-PDO as the sole carbon
ource. Model simulations suggested that it is indeed essential in
his background. The mechanism for lethality according to the sim-
lations is shown schematically in Fig. 1. Speciﬁcally, this strain is
osited to metabolize L-1,2-PDO by ﬁrst converting it to lactalde-
yde. Next, the AldA enzyme converts lactaldehyde to L-lactate,
fter which L-lactate is converted to pyruvate by LldD and enters
entral metabolism. The aldA gene product is predicted to be essen-
ial because, without it, an inﬁnite amount of lactaldehyde would
ccumulate, an infeasible model solution that corresponds to cell
eath.
.3. Evolved K12 (K12PDO) growth on L-1,2-PDO is
ose-dependent
We  next sought to conﬁrm these computational predictions
xperimentally, and started by testing whether the evolved L-
,2-PDO strain grows in L-1,2-PDO in a concentration-dependent
anner. To this end, we grew the K12PDO strain on increasingoncentrations of L-1,2-PDO (1, 2, 4, and 8 g/L). Both the rate and
xtent of bacterial growth increased with increasing L-1,2-PDO
oncentration in a linear dose-response manner (Fig. 2): the growth
ate positively correlated with L-1,2-PDO concentration (Pearsonfurther converted into pyruvate allowing cell growth. The hypothesis is that deleting
aldA (B) will lead to L-lactaldehyde accumulation, which will halt cell growth.
r = 0.990, R2 = 0.979); and so did the biomass (Pearson r = 0.999,
R2 = 0.997).
3.4. Loss of function analysis: aldA deletion abolishes the ability
of the evolved K12PDO to grow on L-1,2-PDO
Using the Lambda Red strategy (Datsenko and Wanner, 2000;
Baba et al., 2006), we precisely deleted aldA from the evolved
K12PDO strain and conﬁrmed the gene deletion with polymerase
chain reaction (PCR). The resulting knockout strain (K12PDOaldA)
readily grew on rich media as well as minimal media supplied with
glucose (M9-glucose); however, unlike the parent K12PDO strain,
the aldA isogenic mutant failed to grow on M9  media supple-
mented with 1,2-PDO as a sole carbon source (Fig. 3). To conﬁrm
that aldA loss has not affected the natural growth of E. coli in any
other aspects, we  deleted aldA in the unevolved K-12 strain. The
generated K12aldA knockout was able to grow on LB, M9-glucose,
but—as expected—did not grow in M9-PDO.
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Fig. 2. Substrate concentration-dependent growth of K12PDO at different L-1,2-PDO concentrations.
L-1,2-PDO was added to the minimal M9  media at increasing concentrations (0.1, 0.2, 0.4, 0.8% w/v). A. Growth curves of K12PDO in M9  supplemented with different L-1,2-
PDO  concentrations. The curves represent OD600 values recorded every 20 min  right after lag phase. Best-ﬁtted natural logarithmic slopes are computed and shown next to
each  growth curve indicating the growth rate. B-C. Growth rates (B) and ﬁnal biomass, expressed as ﬁnal OD600 values (C) at each of the four L-1,2-PDO concentrations are
positively correlated with the substrate concentration, with slopes of 0.008 and 0.08, respectively.
Fig. 3. Loss of function analysis of aldA.
G e (M9
K  intact
E ndard
3
p
L
Prowth curves for K12, K12PDO, and K12PDOaldA in M9  supplied with 0.2% glucos
12PDO can only grow on L-1,2-PDO as a sole carbon source when the aldA gene is
ach  data point represents the mean of four replicates; error bars represent the sta
.5. Complementing the K12PDOaldA strain with a
lasmid-borne copy of aldA restores its ability to grow on
-1,2-PDO
To conﬁrm that the failure of K12PDOaldA to grow on L-1,2-
DO is due to the absence of aldA and not to a secondary mutation Glu, ﬁlled symbols) or 0.2% L-1,2-PDO (M9  0.2% PDO, open symbols) indicating that
, while both the wild-type and aldA-knockout strains readily grow on M9-glucose.
 error of the means.
generated during storage, subculture or genetic manipulation, we
reintroduced a plasmid-borne copy of aldA into the knockout strain.
The resulting K12PDOaldA:pASK-aldA strain was  able to grow on
M9 supplemented with L-1,2-PDO (at 2 g/L) as a sole carbon source.
Bacteria transformed with plasmid-borne genes sometimes fail
to express the genes or express them at very low levels, since
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ome cis-regulatory elements may  be needed for full gene expres-
ion. To verify that aldA was expressed in the complemented
train, we tested for the presence of the gene’s transcript using
everse transcriptase PCR. We  also performed the same analy-
is in the evolved strain, which hasn’t been previously tested
or aldA expression. The evolved K12PDO and the complemented
12PDOaldA:pASK-aldA successfully transcribed aldA, unlike the
nockout strain K12PDOaldA, in which no aldA transcript could
e detected.
. Discussion
The hypothesis about the possible involvement of an aldehyde
ehydrogenase in L-1,2-PDO utilization by E. coli dates back to the
re-genomic era (Hacking et al., 1978). Genetic and biochemical
tudies based on hfr mapping (Chen et al., 1987) and enzymatic
ctivity analysis (Hacking et al., 1978) suggested aldA as one pos-
ible key gene in spontaneous or laboratory-evolved E. coli mutant
trains that grew on L-1,2-PDO. Additionally, AldA and its orthologs
ave been manipulated or exploited in biotechnology for their
nvolvement in the propanediol biosynthesis (but not utilization)
athways in E. coli, Klebsiella, and Citrobacter (Zhang et al., 2006;
lomburg and Gonzalez, 2011; Lawrence et al., 2014). In spite of
hese rather old hypotheses, no direct evidence has been presented
n the role of AldA in the L-1,2-PDO utilization pathway.
Here, we  provide direct genetic evidence for this long-
ypothesized function, showing that aldA is both essential and
ufﬁcient for the L-1,2-PDO utilization phenotype in the laboratory-
volved E. coli K12PDO.
AldA has been known for its broad spectrum as a glycoalde-
yde dehydrogenase that oxidizes -hydroxyaldehyde in several
athways involved in the utilization of monosaccharides such as
-fucose, L-rhamnose, D-arabinose, and L-lyxose (Baldoma and
guilar, 1987; Badia et al., 1991; Quintilla et al., 1991). It has been
lso classiﬁed as a generalist enzyme in a systems-level analysis of
. coli enzyme speciﬁcity (Nam et al., 2012). We  recently showed
hat its involvement in the folate biosynthesis pathway is dispens-
ble and complemented by another E. coli enzyme, PrpC (Aziz et al.,
015b). In the current study, the broad-spectrum of AldA is further
mphasized, as it was conﬁrmed to play an essential role in the
tilization of L,1-2,PDO by E. coli when no other carbon source is
resent. This ﬁnding assigns to this enzyme one more pathway than
reviously expected (Baldoma and Aguilar, 1987).
More generally, this outcome represents a good example of the
obustness of E. coli metabolism, demonstrated by the bacterial
eployment of a possibly broad-spectrum enzyme (here, AldA)
n multiple pathways to survive carbon starvation and to grow
n a non-native substrate when no native carbon source is avail-
ble. Moonlighting and generalist enzymes often play extra roles,
otably when the primary enzymes that catalyze a speciﬁc reac-
ion damaged or mutated. Nam, Lewis, and coworkers showed that
eneralist enzymes have been evolutionarily preserved even when
peciﬁc alternatives are available (Nam et al., 2012). We  believe that
hese generalists may  not only serve as a “backup” when specialists
re lost, damaged, or inhibited, but may  also act as a “reserve” for
daptive functions, when the organism is exposed to an unusual
tress, such as being forced to survive on a nonnative substrate.
he availability of genes encoding such enzymes with dual/multiple
unctions or with broad-spectrum is likely to increase the ﬁtness
nd robustness of a versatile organism, such as E. coli, and may
xplain why genome-scale models often fail to predict gene essen-
iality or synthetic lethality (Aziz et al., 2015a; Guzmán et al., 2015).
In conclusion, using genome-scale metabolic models and sim-
lation experiments, we hypothesized that the gene encoding
ldA plays a key role in E. coli’s adaptively acquired utilization ofesearch 194 (2017) 47–52 51
nonnative L-1,2-PDO, and we used (i) loss of function, (ii) com-
plementation, and (iii) gene expression analyses to prove the
hypothesis. Future studies may  exploit this ﬁnding in strain engi-
neering to improve L-1,2-PDO utilization via modulating AldA
activity or improving its efﬁciency by site-speciﬁc mutagene-
sis. Additionally, given the apparent role of L-1,2-PDO and its
precursors, fucose and rhamnose, in bacterial-host sensing and
bacterial-bacterial communication in the human gut (Pacheco et al.,
2012), the experimentally validated role of AldA in PDO utiliza-
tion may provide a foundation for modulation of this enzyme and
pathway and, in turn, manipulation of the complex sensing and
signaling pathway between resident gut microbiota and invading
outsiders.
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